origins, history and usage of gerovita H3
David Rathborne - Investigative Journalist - Originally published by
White Rose Marketing, Kansas, USA - 1982
GH3 , "Fountain
of Life" tablets has as its starting point the discovery by an Austrian
biochemist, Dr Alfred Einhorn, of the substance "Procaine Hydrochloride".
In 1905 Einhorn successfully synthesised and combined in an aqueous
solution two products which occur naturally within the body (Para-aminobenzoic
acid- PABA - a member of the B vitamin complex and Diethylaminoethanol
"procaine" was simply a label Einhorn hung on his work as a means of
distinguishing it. Procaine itself proved extremely useful as an anaesthetic.
In America it was known as "Novacaine" and was used extensively by the
dental profession. It was highly effective basically non-toxic and had
no addictive qualities. Despite a similarity of name procaine has no
connection whatsoever with cocaine, indeed Einhorn could have settled
for any one of a number of titles when he was casting around for a name.
procaine was discovered in 1905 it appears that little further interest
was taken in it beyond its known anaesthetic use until the late 1940`s
when Dr. Ana Aslan of the National Geriatric Institute in Bucharest,
the capital city of Romania, decided to experiment by using it by means
of injection for the relief of pain in the arthritic joints of elderly
patients. The experiment itself was indeed successful resulting in decreased
pain and increased mobility but, more interestingly the patients began
to exhibit improvements in both physical and mental well-being far beyond
the arthritic benefits.
was too good a medical research scientist to allow this phenomenon to
go unnoticed and immediately set up a highly controlled program into
the "side-effects" of procaine. Basically it was a problem of stabilisation,
procaine rapidly hydrolysed in the body and remained active for a comparatively
short time. If it could be absorbed in greater measure and (hopefully)
proportionately increase the benefits already noticed. Working with
her colleagues Dr. Aslan added potassium metabisulphite and disodium
phosphate to the procaine which had the desired effect of sustaining
it within the body for between 6 and 9 hours. In a word GH3 had arrived!
The "side-effects" of Gerovita as the new compound became known became more marked (listed
later in the following paragraphs) and the legend of Bucharest was born.
The amount of conclusive evidence as to its efficacy is prodigious and
totally irrefutable - including much that was carried out by eminent
medical authorities in America. It follows that individuals or organisations
(professional or Governmental) who sought to challenge or ignore the
evidence were motivated to do so by other and less worldly motives,
than a desire to benefit Humanity .
of course none so blind as those who do not wish to see, and we see
this time and time again in every aspect of the Humanitarian cause.
In 1956 Ana Aslan presented the research findings to the European Congress
for Gerontology meeting in Karlsruhe, West Germany. Her conclusions
were met with widespread skepticism, the fraternity listened politely
but simply didn't believe, and the reason is not difficult to comprehend.
We have all, lay persons and Medical Professionals alike, been educated
to assume that one takes a single remedy for a single problem - e.g.
an aspirin for headache, another type of powder for stomach ache. For
anyone to suggest, no matter with what sincerity, that a (previously
considered). Dental anaesthetic held the secret of the mystery of rejuvenated
cell life was rather more than could be mentally or emotionally digested.
had lost the battle - but she had no intention of losing the war! Intent
on proving her case beyond any reasonable doubt she then embarked on
one of the worlds greatest research programs, probably the largest and
most thorough double-blind study ever undertaken in the history of the
health industry. For almost two years 15,000 workers aged between 38
and 62 years were observed throughout Romania. Over 400 Doctors staffing
a network of 154 clinics participated in the program. All the patients
were healthy but ageing and a whole range of astonishing results were
forthcoming. Amongst those using Gerovita sickness diminished by over
40% (measured in days off work) prompting that Government to heavily
subsidise the distribution of GH3 throughout the population as an assist
to the working economy.
blood pressures normalised (either up or down), respiratory functions
improved, muscular vigour increased, basic sex drive increased, arthritic
conditions improved, peptic ulcers disappeared, cholesterol levels normalised
etc etc. In a word the degenerative effects of advancing age were halted
and even reversed to a significant extent in up to 80% of the subjects
under scrutiny. Those who were not receiving GH3 gerovita received a
"placebo" instead, but no one - including the medical staff - knew who
was getting which! (hence the term "double-blind"), only the institute
computer held the secret.
the study an influenza epidemic swept across Europe and was no respecter
of national boundaries. Communist and Capitalist countries alike suffered
mightily, but whereas the death rate amongst the research group on gerovita
GH3 was 2.7%, amongst those receiving "normal" medical treatment it
was 13.9% - more than 5 times higher! This in itself was an indication
of the heightened level of basic sound good health and resistance against
infection produced by the daily ingestion of this remarkable food. Dr
Aslan was met, again by the European Congress of Gerontology which carefully
examined the mountain of evidence she now presented and, being convinced
of its accuracy, this time accepted it as a basis for the truth of her
Ana Aslan was received warmly and she received tremendous acclaim for
testing now took place in a number of countries throughout Western and
Eastern Europe, the United Kingdom and finally America. Where researchers
followed the Aslan method the same astonishing results were forthcoming,
where they did not (and one would be entitled to ask why they did not?)
the results were minimal and were arrived at by a simple ruse of using
only Procaine without the buffering agents. Strangely enough at that
time - and to this day in America - these were the only results widely
of availability to the general public the (over 400) correct research
programs and results were basically non-existent and once again it is
in order to ask "why"? Unfortunately asking "why" is not a very profitable
occupation as the authorities who went out of their way to produce false
conclusions decrying Gerovita are not in the business of explaining
themselves and in any event the story does not end at that point. As
far as GH3 was concerned the floodgates were open, country after country
accepted the Aslan findings, often coming to their decisions after confirming
matters through their own research.
As we look
at the situation now over 70 countries have GH3 accessible to their
people, without prescription, and an estimated fifty million users have
benefited to a greater or lesser degree. In Germany one of the worlds
greatest consumers of alternative and herbal products a version called
KH3 is manufactured (containing half the procaine and various vitamins)
and is now one of the top ten most popular dietary supplements marketed
there. In America a Dr. Sapse who, as an intern working with Dr. Aslan,
never forgot the evidence of his own eyes, approached the Food and Drug
Administration with a view to obtaining pre-market permission to test
the product as an anti-depressant for the elderly. This was granted
and Sapse raised the money to start up his company (Rom-Amer) to market
gerovita GH3. Unfortunately for him no sooner had he passed GH3 through
Part One (Safety) of the three FDA trials required and was well under
way the F.D.A. changed the rules!
that wild reports in the media ("The Elixir of Life", "Will we live
for ever", "Anti-aging miracle" and suchlike flights of editorial
flights of fancy) alarmed them to the point of informing Sapse that
he should research the product on a vast number of patients over a limitless
number of years to confirm the claims of the (Newspaper) media men.
In vain did he protest his interest was limited to that of one factor,
they were adamant. The financial implications of this development were
of such horrendous proportions that the good Doctor was literally stopped
in his tracks and his company bankrupted.
It is of
course intriguing to conjecture why the F.D.A did this considering that
Sapse had restricted himself entirely to the natural anti-depressant
aspect of GH3 and that the Authority itself had already decided there
was no safety problem with the product (based on American research)
- an opinion they maintain to this day. Perhaps as with many bureaucratic
F.D.A. saw itself operating at a higher level than mere public interest,
perhaps it saw no requirement to explain its actions to those humdrum
members of society whose lot it was to support. We are left therefore
in the position of having to decide for ourselves what the truth may
be; one opinion is expressed thus. If we take as a standpoint the fact
that GH3 works - and research provides overwhelming evidence that it
does, we then have to consider what effect this seemingly beneficial
nutrient would have were it to be also generally available world-wide
(not just accessible, as has been the case for some 20 years in many
developed countries world-wide) - including the communist block where
there is no money to be made from discoveries of this nature as all
health industry is state run and state owned.
to the riddle lies in the known fact that Gerovita GH3 does work, not
only that but it works - "across the Board" - on a number of seemingly
unrelated conditions and that these conditions are presently being "treated"
(for want of a better word) by an ever increasing range of highly expensive
unnatural drugs which produce an ever increasing range of hideous side-effects
which are then treated by more unnatural drugs - which produce more
side-effects, which are then treated by…etc…etc.
the matter into simple and accurate perspective, if true formula GH3
was easily marketable to the public it would strike a monumental blow
at the lucrative synthetic drug industry, an industry which in size,
scope and revenue is second only to the Oil and Arms industrys. It is
well known that the suppression of competing products and materials
has long been commonplace in all large industries world-wide. For years
the recording tape was held up by the disc manufacturers as it would
have decimated their business. Similarly the "Pogue" carburettor, patented
in 1933 and giving 204 miles per gallon when fitted to a gas guzzling
Ford L.T.D. - with greater power, vanished off the scene as soon as
mention was made of it in the press. However we cannot isolate one group
as being the only obstructive factor in the case of Gerovita GH3, they
needed help to keep it off the market, they could not do it alone. To
whom should they turn for this help, why to those who have governmental
authority in these matters - The Food and Drug Administration and other
of the American Medical Association? Why the reluctance of these powerful
entities to carry out swift and accurate research (using GH3 not just
straight procaine) to "satisfy themselves" on what the rest of the world
has known for two decades. Here again we must suggest perhaps vested
interest. And what of the efficacy of the drugs which the F.D.A. and
other medical authorities are so keen to promote throughout the health
industry. Is it not the case that the use of unnatural drugs has spawned
an entire new financial bonanza. One whereby the long suffering public
is now prescribed lethal and near lethal substances to "treat symptoms"
rather than receiving help to cure their conditions! Any patient who
is continually receiving highly expensive treatment for his symptoms
is worth much more to the medical industry than one who is cured. It's
a fair question to ask - where do the Medical Associations stand in
the matter of Gerovita? The answer is they don't, they have done a highly
professional job of ignoring it totally, in stark and shameful contrast
to their more enlightened brethren.
have to decide for themselves. None of the participants are likely to
explain their actions so it remains a matter of opinion. Our grateful
thanks to those in whom we place our trust.